Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CYTOKINE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
AI-generated illustration
Regenerate portrait ↻| Name | CYTOKINE |
| Key Genes/Proteins | ABL1, ALZHEIMER, AMYLOID, amyotrophic lateral sclerosis, ANXIETY |
| Related Diseases | aging, Alzheimer'S Disease |
Knowledge base pages for this entity
graph TD
CYTOKINE["CYTOKINE"]
CYTOKINE ---|"co-discussed"| MITOCHONDRIA["MITOCHONDRIA"]
CYTOKINE ---|"co-discussed"| TDP_43["TDP-43"]
CYTOKINE ---|"co-discussed"| ER_STRESS["ER STRESS"]
CYTOKINE ---|"co-discussed"| IL6["IL6"]
CYTOKINE ---|"co-discussed"| OCLN["OCLN"]
CYTOKINE ---|"co-discussed"| MICROGLIA["MICROGLIA"]
ALS["ALS"] ---|"co-discussed"| CYTOKINE
CLDN5["CLDN5"] ---|"co-discussed"| CYTOKINE
AUTOPHAGY["AUTOPHAGY"] ---|"co-discussed"| CYTOKINE
COMPLEMENT["COMPLEMENT"] ---|"co-discussed"| CYTOKINE
APOPTOSIS["APOPTOSIS"] ---|"co-discussed"| CYTOKINE
AKT["AKT"] ---|"co-discussed"| CYTOKINE| Target | Relation | Type | Str |
|---|---|---|---|
| Neurodegeneration | associated_with | disease | 0.60 |
| Multiple Sclerosis | associated_with | disease | 0.60 |
| Parkinson | protects_against | disease | 0.60 |
| Aging | therapeutic_target | disease | 0.60 |
| Diabetes | inhibits | disease | 0.60 |
| Anxiety | associated_with | disease | 0.60 |
| Lymphoma | phosphorylates | disease | 0.60 |
| Chronic Pain | regulates | disease | 0.60 |
| Tauopathy | activates | disease | 0.60 |
| Cancer | regulates | disease | 0.60 |
| Glioblastoma | activates | disease | 0.60 |
| Hypertension | contributes_to | disease | 0.60 |
| Huntington | activates | disease | 0.60 |
| Aging | associated_with | disease | 0.60 |
| Senescence | associated_with | disease | 0.60 |
| Depression | interacts_with | disease | 0.60 |
| Senescence | activates | disease | 0.60 |
| Parkinson | regulates | disease | 0.60 |
| Ferroptosis | associated_with | disease | 0.60 |
| Neurodegeneration | biomarker_for | disease | 0.60 |
| Cancer | associated_with | disease | 0.60 |
| Atherosclerosis | regulates | disease | 0.60 |
| Parkinson | associated_with | disease | 0.60 |
| Neurodegeneration | interacts_with | disease | 0.60 |
| Neuropathy | inhibits | disease | 0.60 |
| Atherosclerosis | contributes_to | disease | 0.60 |
| Dementia | inhibits | disease | 0.60 |
| Neuropathy | causes | disease | 0.60 |
| Neurodegeneration | therapeutic_target | disease | 0.60 |
| Autism | expressed_in | disease | 0.60 |
| Parkinson | interacts_with | disease | 0.60 |
| Als | interacts_with | disease | 0.60 |
| Multiple Sclerosis | activates | disease | 0.60 |
| Cancer | causes | disease | 0.60 |
| Migraine | activates | disease | 0.60 |
| Prion Disease | expressed_in | disease | 0.60 |
| Glioblastoma | expressed_in | disease | 0.60 |
| Encephalitis | associated_with | disease | 0.60 |
| Neuroinflammation | biomarker_for | disease | 0.60 |
| Aging | inhibits | disease | 0.60 |
| Leukemia | activates | disease | 0.60 |
| Pyroptosis | activates | disease | 0.60 |
| Hypertension | activates | disease | 0.60 |
| Stroke | interacts_with | disease | 0.60 |
| Aging | protects_against | disease | 0.60 |
| Senescence | protects_against | disease | 0.60 |
| Alzheimer | therapeutic_target | disease | 0.60 |
| Ischemia | causes | disease | 0.60 |
| Als | therapeutic_target | disease | 0.60 |
| Als | associated_with | disease | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| LIF | inhibits | gene | 0.60 |
| CLDN1 | inhibits | gene | 0.60 |
| RNA | therapeutic_target | gene | 0.60 |
| COMPLEMENT | activates | gene | 0.60 |
| ANXIETY | activates | gene | 0.60 |
| ROS | inhibits | gene | 0.60 |
| CERS2 | regulates | gene | 0.60 |
| HSPA5 | therapeutic_target | gene | 0.60 |
| PPP1R15A | therapeutic_target | gene | 0.60 |
| CNTNAP4 | contributes_to | gene | 0.60 |
| BMAL1 | activates | gene | 0.60 |
| DEPRESSION | activates | gene | 0.60 |
| IL-13 | inhibits | gene | 0.60 |
| CLDN4 | inhibits | gene | 0.60 |
| CYTOKINES | regulates | gene | 0.60 |
| IL-10 | activates | gene | 0.60 |
| CXCL1 | inhibits | gene | 0.60 |
| IRE1 | therapeutic_target | gene | 0.60 |
| XBP1 | therapeutic_target | gene | 0.60 |
| IL23A | inhibits | gene | 0.60 |
| TCR | activates | gene | 0.60 |
| NEURON | activates | gene | 0.60 |
| IL-6 | activates | gene | 0.60 |
| CRY1 | activates | gene | 0.60 |
| TNFRSF1A | activates | gene | 0.60 |
| OCLN | activates | gene | 0.60 |
| IBA1 | activates | gene | 0.60 |
| NRF2 | inhibits | gene | 0.60 |
| IL-4 | inhibits | gene | 0.60 |
| STAT6 | inhibits | gene | 0.60 |
| ROS | regulates | gene | 0.60 |
| ALZHEIMER | therapeutic_target | gene | 0.60 |
| BACE1 | therapeutic_target | gene | 0.60 |
| REL | regulates | gene | 0.60 |
| HSPG2 | interacts_with | gene | 0.60 |
| IL6 | inhibits | gene | 0.60 |
| ATF4 | therapeutic_target | gene | 0.60 |
| DDIT3 | therapeutic_target | gene | 0.60 |
| IL12B | inhibits | gene | 0.60 |
| OCLN | inhibits | gene | 0.60 |
| PERK | therapeutic_target | gene | 0.60 |
| CYTOKINES | inhibits | gene | 0.60 |
| CLDN5 | inhibits | gene | 0.60 |
| IFN | activates | gene | 0.60 |
| CD8 | expressed_in | gene | 0.60 |
| PARKINSON | expressed_in | gene | 0.60 |
| HEDGEHOG | activates | gene | 0.60 |
| HIPPO | activates | gene | 0.60 |
| ICAM1 | activates | gene | 0.60 |
| OCLN | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Astrocyte-Microglia Communication Rebalancing via Cytokine M | 0.655 | neurodegeneration | Which cell types show the most significa |
| Mitochondrial-Cytokine Axis Modulation | 0.532 | neurodegeneration | Gene expression changes in aging mouse b |
| STAT3 Epigenetic Priming as Mechanism of Peripheral Cytokine | 0.370 | immunomics | Systemic immune profiling in neurodegene |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| LPS-induced mouse model of depression with synaptic loss analysis | validation | depression | 0.900 | 0.00 | LPS-treated mice | proposed | N/A |
| Network pharmacology analysis of QTJD active compounds and pathways | exploratory | Mycoplasma pneumoniae pneumoni | 0.900 | 0.00 | computational network analysis | proposed | N/A |
| Bidirectional Mendelian randomization analysis of C1Q and ischemic str | exploratory | Ischemic stroke, Atheroscleros | 0.900 | 0.00 | Human genetic association data | proposed | N/A |
| Bidirectional Mendelian randomization analysis of C1Q and ischemic str | exploratory | Ischemic stroke (large artery | 0.900 | 0.00 | human genetic data | proposed | N/A |
| C1q neutralizing antibody intervention in depression model | validation | depression | 0.850 | 0.00 | LPS-treated mice with C1q anti | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning CYTOKINE in their description or question text
No additional research found